The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media

被引:14
|
作者
Emonts, Marieke
Wiertsema, Selma P.
Veenhoven, Reinier H.
Houwing-Duistermaat, Jeanine J.
Walraven, Vanessa
de Groot, Ronald
Hermans, Peter W. M.
Sanders, Elisabeth A. M.
机构
[1] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Pediat Immunol, Utrecht, Netherlands
[3] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands
关键词
plasminogen activator inhibitor-1; polymorphism; otitis media;
D O I
10.1542/peds.2006-1390
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. Plasminogen activator inhibitor-1 counterregulates cell migration, adhesion, and tissue repair. The PAI1 4G/5G promoter polymorphism has an effect on expression levels of PAI1. After a first acute otitis media episode, children are at increased risk for a next episode. Because the PAI1 4G allele is associated with higher plasminogen activator inhibitor-1 production and, hence, decreased tissue repair, we hypothesize that this allele may contribute to increased recurrence of acute otitis media. Patients and Methods. The PAI1 4G/5G polymorphism was genotyped in 348 Dutch children aged 1 to 7 years who were suffering from recurrent acute otitis media and participating in a randomized, controlled trial and 463 healthy control subjects, representative of the general population. Results. No significant difference in PAI1 genotype distribution between the whole acute otitis media group and control subjects was observed. However, children with the PAI1 4G/4G genotype had an increased risk of more frequent acute otitis media episodes compared with those who were homozygous for the 5G variant, also after correction for cofactors. This finding was attributable to children < 4 years of age. Conclusions. Our findings suggest that the PAI1 4G/4G genotype is associated with an increased risk for the otitis-prone condition, potentially because of impaired healing after a previous otitis media episode.
引用
收藏
页码:E317 / E323
页数:7
相关论文
共 50 条
  • [21] The common -675 4G/5G polymorphism in the plasminogen activator inhibitor –1 gene is strongly associated with obesity
    J. Hoffstedt
    I.-L. Andersson
    L. Persson
    B. Isaksson
    P. Arner
    Diabetologia, 2002, 45 : 584 - 587
  • [22] 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly
    Hoekstra, T
    Geleijnse, JM
    Kluft, C
    Giltay, EJ
    Kok, FJ
    Schouten, EG
    STROKE, 2003, 34 (12) : 2822 - 2828
  • [23] Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism
    Brogren, Helen
    Wallmark, Karin
    Jern, Sverker
    Karlsson, Lena
    THROMBOSIS RESEARCH, 2008, 121 (06) : 793 - 797
  • [24] Clinicopathological Significance of Plasminogen Activator Inhibitor-1 Promoter 4G/5G Polymorphism in Breast Cancer: A Meta-analysis
    Lee, Ju-Han
    Kim, Younghye
    Choi, Jung-Woo
    Kim, Young-Sik
    ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (01) : 39 - 45
  • [25] Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population
    Cao, Yuezhou
    Chen, Weixian
    Qian, Yun
    Zeng, Yanying
    Liu, Wenhua
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (12) : 874 - 881
  • [26] Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
    Li, Xuejiao
    Liu, Yukun
    Zhang, Rui
    Tan, Jianping
    Chen, Libin
    Liu, Yinglin
    MEDICAL SCIENCE MONITOR, 2015, 21 : 1051 - 1056
  • [27] Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Adults with Splanchnic Vein Thrombosis: A Case–Control Study
    Arpitha Kollabathula
    Saniya Sharma
    Narender Kumar
    Jasmina Ahluwalia
    Reena Das
    Neelam Varma
    Surinder Singh Rana
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 169 - 172
  • [28] Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
    Zhang, Tengyue
    Pang, Chong
    Li, Ningdong
    Zhou, Elaine
    Zhao, Kanxing
    BMC MEDICINE, 2013, 11
  • [29] Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
    Tengyue Zhang
    Chong Pang
    Ningdong Li
    Elaine Zhou
    Kanxing Zhao
    BMC Medicine, 11
  • [30] Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study
    Giurgea, Georgiana-Aura
    Brunner-Ziegler, Sophie
    Jilma, Bernd
    Sunder-Plassmann, Raute
    Koppensteiner, Renate
    Gremmel, Thomas
    THROMBOSIS RESEARCH, 2017, 153 : 71 - 75